No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.5x · 10Y median 2.3x · 4th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 27
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T22:04:40.107Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T22:04:40.107Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T22:04:40.107Z. Latest historical point 2026-08-06. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T22:04:40.107Z. Latest historical point 2025-08-07. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T22:04:40.107Z. Latest historical point 2026-08-06.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T22:04:40.107Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T22:04:40.107Z. Latest historical point 2026-08-06. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T22:04:40.107Z. Latest historical point 2025-08-07. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Vital Farms, Inc. (VITL) stock was $9.40 as of Oct 6, 2026, 4:00 PM EDT, up 1.62% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -77.8% · 3-year avg -5.6%/yr · 5-year avg -11.7%/yr
Vital Farms, Inc. is a values-driven food enterprise dedicated to providing ethically sourced, pasture-raised products across the United States.
Agricultural Farm Products · Austin, TX
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 3, 2026
28 days away
EPS Estimate
-0.13
Revenue Est.
$186.64M
Last Quarter Results
EPS
$-0.47
vs Estimate
$-0.47
Revenue
$166.03M
vs Estimate
$160.24M
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1VITL | $402.78M | $9.40 | +1.62% | -77.83% | -11.72% | N/A | N/A |
| 2PRE | $346.81M | $20.40 | -2.67% | +46.61% | -28.80% | N/A | vs VITL |
| 3AGCC | $341.80M | $15.00 | +0.00% | N/A | N/A | N/A | vs VITL |
| 4VFF | $339.85M | $2.79 | +2.57% | -4.21% | -19.61% | +9.83% | vs VITL |
| 5SNDL | $320.17M | $1.23 | -1.60% | -51.38% | -27.89% | N/A | vs VITL |
| 6AFRI | $313.86M | $11.64 | +3.28% | +29.53% | +2.34% | N/A | vs VITL |
forward FY estimate
N/A
Consensus Rating
Based on 9 analysts
Average Price Target
$13.22
+40.7% upside
Low
$10.00
Current
$9.40
High
$18.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.12 | $-0.09 | $-0.04 | 3 |
| Quarter ending Dec 2026 | $0.13 | $0.20 | $0.25 | 3 |
| Quarter ending Mar 2027 | $0.00 | $0.00 | $0.00 | 1 |
| Quarter ending Jun 2027 | $-0.07 | $-0.07 | $-0.06 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-0.65 | $-0.49 | $-0.29 | 4 |
| FY 2027 | $0.06 | $0.32 | $0.48 | 5 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $182.72M | $186.64M | $191.05M | 6 |
| Quarter ending Dec 2026 | $227.23M | $229.71M | $234.49M | 6 |
| Quarter ending Mar 2027 | $184.15M | $191.26M | $197.14M | 5 |
| Quarter ending Jun 2027 | $178.30M | $185.18M | $190.88M | 5 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $766.58M | $769.55M | $771.63M | 7 |
| FY 2027 | $808.49M | $823.59M | $831.74M | 7 |
